TrialSignal transduction and targeted therapy2024

Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliary tract cancer or pancreatic ductal adenocarcinoma: a phase II trial.

Lixia Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.